Literature DB >> 21720875

Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas.

Paula Hoff1, T Gaber, K Schmidt-Bleek, U Sentürk, C L Tran, K Blankenstein, S Lütkecosmann, J Bredahl, H J Schüler, P Simon, G Wassilew, F Unterhauser, G R Burmester, G Schmidmaier, C Perka, G N Duda, F Buttgereit.   

Abstract

For patients who are known to have an impaired immune system, bone healing is often impaired. Therefore, it has been suggested that an effectively functioning immune system will have an influence on the quality of bone healing. Here, we demonstrate that cells within the fracture hematoma of immunologically restricted patients (1) exhibit a disturbed osteogenic differentiation (normal SPP1 but diminished RUNX2 expression), (2) show a strong inflammatory reaction (high IL8 and CXCR4), and (3) react on local hypoxia (high expression of HIF1A) but with inadequate target gene responses (diminished LDHA and PGK1 expression). Thus, it is already within the early inflammatory phase of fracture healing that the local gene expression in fracture hematomas of immunologically restricted patients points toward a critical regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720875     DOI: 10.1007/s12026-011-8235-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  25 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Primary immunodeficiency and autoimmunity: lessons from human diseases.

Authors:  G J Arason; G H Jorgensen; B R Ludviksson
Journal:  Scand J Immunol       Date:  2010-05       Impact factor: 3.487

3.  CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability.

Authors:  Jasmin Lienau; Hanna Schell; Devakara R Epari; Norbert Schütze; Franz Jakob; Georg N Duda; Hermann J Bail
Journal:  J Orthop Res       Date:  2006-02       Impact factor: 3.494

4.  The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model.

Authors:  Kazuhiro Taguchi; Rei Ogawa; Makoto Migita; Hideki Hanawa; Hiromoto Ito; Hideo Orimo
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

5.  Human early fracture hematoma is characterized by inflammation and hypoxia.

Authors:  Paula Kolar; Timo Gaber; Carsten Perka; Georg N Duda; Frank Buttgereit
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

6.  Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats.

Authors:  Niels Follak; Ingrid Klöting; Harry Merk
Journal:  Diabetes Metab Res Rev       Date:  2005 May-Jun       Impact factor: 4.876

7.  Osteogenic protein-1 overcomes inhibition of fracture healing in the diabetic rat: a pilot study.

Authors:  Louis S Kidder; Xinqian Chen; Andrew H Schmidt; William D Lew
Journal:  Clin Orthop Relat Res       Date:  2008-07-29       Impact factor: 4.176

8.  Hip fracture in rheumatoid arthritis.

Authors:  B Strömqvist
Journal:  Acta Orthop Scand       Date:  1984-12

9.  Ageing is associated with a decline in peripheral blood CD56bright NK cells.

Authors:  Shivani M Chidrawar; Naeem Khan; Y L Tracey Chan; Laxman Nayak; Paul A H Moss
Journal:  Immun Ageing       Date:  2006-11-29       Impact factor: 6.400

10.  Immunity and age: living in the past?

Authors:  David L Woodland; Marcia A Blackman
Journal:  Trends Immunol       Date:  2006-05-30       Impact factor: 16.687

View more
  14 in total

1.  Hypoxia-inducible factor-1α antagonizes the hypoxia-mediated osteoblast cell viability reduction by inhibiting apoptosis.

Authors:  Guicun Xu; Mingming Xue; Haiyan Wang; Chun Xiang
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

2.  Immunological characterization of the early human fracture hematoma.

Authors:  Paula Hoff; T Gaber; C Strehl; K Schmidt-Bleek; A Lang; D Huscher; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

3.  Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma model.

Authors:  Paula Hoff; Patrick Maschmeyer; Timo Gaber; Tabea Schütze; Tobias Raue; Katharina Schmidt-Bleek; René Dziurla; Saskia Schellmann; Ferenz Leonard Lohanatha; Eric Röhner; Andrea Ode; Gerd-Rüdiger Burmester; Georg N Duda; Carsten Perka; Frank Buttgereit
Journal:  Cell Mol Immunol       Date:  2013-02-11       Impact factor: 11.530

4.  Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner.

Authors:  Markus Wagegg; Timo Gaber; Ferenz L Lohanatha; Martin Hahne; Cindy Strehl; Monique Fangradt; Cam Loan Tran; Kerstin Schönbeck; Paula Hoff; Andrea Ode; Carsten Perka; Georg N Duda; Frank Buttgereit
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 5.  The haematoma and its role in bone healing.

Authors:  H Schell; G N Duda; A Peters; S Tsitsilonis; K A Johnson; K Schmidt-Bleek
Journal:  J Exp Orthop       Date:  2017-02-07

6.  A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Authors:  Paula Hoff; Timo Gaber; Cindy Strehl; Manuela Jakstadt; Holger Hoff; Katharina Schmidt-Bleek; Annemarie Lang; Eric Röhner; Dörte Huscher; Georg Matziolis; Gerd-Rüdiger Burmester; Gerhard Schmidmaier; Carsten Perka; Georg N Duda; Frank Buttgereit
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

7.  Experience in the Adaptive Immunity Impacts Bone Homeostasis, Remodeling, and Healing.

Authors:  Christian H Bucher; Claudia Schlundt; Dag Wulsten; F Andrea Sass; Sebastian Wendler; Agnes Ellinghaus; Tobias Thiele; Ricarda Seemann; Bettina M Willie; Hans-Dieter Volk; Georg N Duda; Katharina Schmidt-Bleek
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 8.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17

9.  Immunoregulation of bone remodelling.

Authors:  Ajai Singh; Abbass A Mehdi; Rajeshwer N Srivastava; Nar Singh Verma
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05

10.  CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells.

Authors:  Timo Gaber; Kerstin Schönbeck; Holger Hoff; Cam Loan Tran; Cindy Strehl; Annemarie Lang; Sarah Ohrndorf; Moritz Pfeiffenberger; Eric Röhner; Georg Matziolis; Gerd-R Burmester; Frank Buttgereit; Paula Hoff
Journal:  Int J Mol Sci       Date:  2018-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.